Artículos por temáticas

Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer's Disease

Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, Pasquini S, Suresh RR, Kim SW, Volkow ND, Jacobson KA, Gessi S.

Molecules. 2022 Apr 21;27(9):2680. doi: 10.3390/molecules27092680.

Biomarkers in Alzheimer Disease and Other Dementias: What's Next into Pathophysiology to Support Clinical Practice and Drug Development

Bougea A.

Medicina (Kaunas). 2022 Sep 30;58(10):1374. doi: 10.3390/medicina58101374.

Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes

Dai R, Sun Y, Su R, Gao H.

Biomed Pharmacother. 2022 Oct;154:113576. doi: 10.1016/j.biopha.2022.113576. Epub 2022 Aug 22.

The Alteration of Neurogenesis and Pathological Markers in Alzheimer's Disease After Deep Brain Stimulation

Nassehi B, Kocabicak E, Temel Y, Hescham S.

Turk Neurosurg. 2022;32(4):535-548. doi: 10.5137/1019-5149.JTN.35598-21.2.

Efficacy and safety of blood derivatives therapy in Alzheimer's disease: a systematic review and meta-analysis

Fei Z, Pan B, Pei R, Chen Z, Du X, Cao H, Li C.

Syst Rev. 2022 Nov 29;11(1):256. doi: 10.1186/s13643-022-02115-y.

Exploring Plausible Therapeutic Targets for Alzheimer's Disease using Multi-omics Approach, Machine Learning and Docking

Parvathy Dharshini SA, Sneha NP, Yesudhas D, Kulandaisamy A, Rangaswamy U, Shanmugam A, Taguchi YH, Gromiha MM.

Curr Top Med Chem. 2022;22(22):1868-1879. doi: 10.2174/1568026622666220902110115.

Efficacy and safety of sodium oligomannate in the treatment of Alzheimer's disease

Zhang LF, Zhang YP, Lin PX, Xue LH.

Pak J Pharm Sci. 2022 May;35(3):741-745.

New Possibilities in the Therapeutic Approach to Alzheimer's Disease

Doroszkiewicz J, Mroczko B.

Int J Mol Sci. 2022 Aug 10;23(16):8902. doi: 10.3390/ijms23168902.

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential

Olichney J, Xia J, Church KJ, Moebius HJ.

Neural Plast. 2022 Nov 8;2022:2104880. doi: 10.1155/2022/2104880. eCollection 2022.

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases

Fan Y, Chen Z, Zhang M.

J Transl Med. 2022 Jun 27;20(1):291. doi: 10.1186/s12967-022-03493-6.

Applications of Carbon Dots for the Treatment of Alzheimer's Disease

Guo F, Li Q, Zhang X, Liu Y, Jiang J, Cheng S, Yu S, Zhang X, Liu F, Li Y, Rose G, Zhang H.

Int J Nanomedicine. 2022 Dec 23;17:6621-6638. doi: 10.2147/IJN.S388030. eCollection 2022.

The Role of Resveratrol in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review

Buglio DS, Marton LT, Laurindo LF, Guiguer EL, Araújo AC, Buchaim RL, Goulart RA, Rubira CJ, Barbalho SM.

J Med Food. 2022 Aug;25(8):797-806. doi: 10.1089/jmf.2021.0084. Epub 2022 Mar 28.

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect

Ferreira I, Rauter AP, Bandarra NM.

Mar Drugs. 2022 Oct 25;20(11):662. doi: 10.3390/md20110662.

Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease

Kumar B, Thakur A, Dwivedi AR, Kumar R, Kumar V.

Curr Med Chem. 2022;29(10):1757-1803. doi: 10.2174/0929867328666210512005508.

Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases

Liu W, Wang G, Wang Z, Wang G, Huang J, Liu B.

Drug Discov Today. 2022 Jul;27(7):1994-2007. doi: 10.1016/j.drudis.2022.04.003. Epub 2022 Apr 6.